48.30
0.00
(0.00%)
Pre-market: 46.80
-1.50
(-3.11%)
May 24, 8:22am GMT-4
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
| Range | - |
| 52 week | 40.75 - 55.68 |
| Open | - |
| Vol / Avg. | 2,653.00/688.00 |
| Mkt cap | 38,140.87M |
| P/E | - |
| Div/yield | - |
| EPS | - |
| Shares | - |
| Beta | 0.06 |
| Inst. own | - |
Events
Jul 29, 2013
Q1 2014 Takeda Pharmaceutical Co Ltd Earnings Release
Jun 25, 2013
Takeda Pharmaceutical Co Ltd Annual Shareholder Meeting (Japanese)
- 9:00pm GMT-4 -
May 9, 2013
Full Year 2013 Takeda Pharmaceutical Co Ltd Earnings and Mid-Range Growth Strategy Conference Call
May 9, 2013
Full Year 2013 Takeda Pharmaceutical Co Ltd Earnings and Mid-Range Growth Strategy Presentation (Japanese)
May 9, 2013
Full Year 2013 Takeda Pharmaceutical Co Ltd Earnings and Mid-Range Growth Strategy Presentation
Mar 19, 2013
NPS Pharmaceuticals and Takeda Revise Agreements and NPS Re-Gains Full Worldwide Rights to Teduglutide and Recombinant Human Parathyroid Hormone 1-84- Conference Call
Mar 11, 2013
Takeda Pharmaceutical Co Ltd at EBD BIO-Europe Spring
Feb 25, 2013
Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS� (peginesatide) Injection - Conference Call
|
|
External links
Discussion Group - Google Finance
Advertisement